Senhwa Biosciences Received US FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection

Our Bureau

Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced today that U.S. Food and Drug Administration has approved its Phase II IND application of Silmitasertib(CX-4945) to treat patients with community-acquired pneumonia (CAP) caused by viral infection. The trial […]

Global Hospital Information System Market worth $ 48.35 Billion by 2027 At 12.65% CAGR Rate, Says Brandessence Market Research

Our Bureau

Pune: Brandessence Market Research has published a new report on HIS, According to Study “Global Hospital Information System (HIS) Market is valued at USD 14.70 Billion in 2020 and expected to reach USD 48.35 Billion by 2027 with a CAGR of 12.65% over the forecast period”. During Covid-19 pandemic, there is positive impact on hospital […]

Subscribe Now